Elevated expression of P4HB has been reported in several solid tumors, such as ovarian cancer (Bonome et al., 2008), bladder cancer (Lyu et al., 2020; Wang et al., 2020), and prostate cancer (Welsh et al., 2001; Singh et al., 2002). Here, P4HB is linked to urinary bladder carcinoma.